Trial Will Examine Effectiveness of a Mechanical Device for People With End-Stage Heart Failure
Temple University Health SystemA trial now underway at Temple University Hospital will examine the efficacy, safety and cost-effectiveness of using the Left Ventricular Assist Device (LVAD) as a permanent treatment of end-stage heart failure. The LVAD -- about the size of an outstretched hand -- is a two-pound mechanical device that pumps blood out of the heart to the body. In recent years, it has been used as a temporary "bridge" to heart transplant, keeping the sickest transplant candidates alive until they receive a new heart. This trial will push the limits of the LVAD.